← Leaderboards
Joyce E. Bischoff
Children'S Hospital Boston
$21,924,378
Attributed
$31,110,071
Total exposure
15
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$31,110,071 · 15
By mechanism
R01$26,089,653 · 6
P01$3,682,190 · 6
T32$893,317 · 1
R21$426,911 · 1
R13$18,000 · 1
Top collaborators
- Arin K. Greene12 shared
- Elena Aikawa8 shared
- Robert A Levine8 shared
- Zoltan P Arany2 shared
- Charles A Parkos1 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsEndothelial CellsMolecularBlood VesselsPreventGrowthPathway InteractionsIn VivoBaseTissuesIn VitroSpecimenStem CellsChildSignal TransductionInfantHemangiomaEndotheliumCell TypeTumorImplantAnimal ModelInsightProperty
Grant awards (65)
Blood vessel assembly from multipotent hemangioma-derived stem cells$734,971
R01 · FY2025 · HL · contact PI
Pediatric Surgeon-Scientist Training Program in Vascular Diseases$280,007
T32 · FY2025 · HD
Blood vessel assembly from multipotent hemangioma-derived stem cells$754,352
R01 · FY2024 · HL · contact PI
Pediatric Surgeon-Scientist Training Program in Vascular Diseases$277,104
T32 · FY2024 · HD
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology$840,738
R01 · FY2023 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$494,240
R01 · FY2023 · HL · contact PI
Pediatric Surgeon-Scientist Training Program in Vascular Diseases$258,198
T32 · FY2023 · HD
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology$840,738
R01 · FY2022 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$494,240
R01 · FY2022 · HL · contact PI
Pediatric Surgeon-Scientist Training Program in Vascular Diseases$78,008
T32 · FY2022 · HD
Improving Mitral Compensation In Ischemic Regurgitation$1,383,663
R01 · FY2021 · HL
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology$840,738
R01 · FY2021 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$504,335
R01 · FY2021 · HL · contact PI
Improving Mitral Compensation In Ischemic Regurgitation$1,383,663
R01 · FY2020 · HL
Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biology$889,388
R01 · FY2020 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$534,673
R01 · FY2020 · HL · contact PI
Improving Mitral Compensation In Ischemic Regurgitation$1,377,128
R01 · FY2019 · HL
Blood vessel assembly from multipotent hemangioma-derived stem cells$443,582
R01 · FY2019 · HL · contact PI
Capillary malformation: From somatic GNAQ mutations and disrupted endothelial biology$442,500
R01 · FY2019 · HL · contact PI
Improving Mitral Compensation In Ischemic Regurgitation$1,413,244
R01 · FY2018 · HL
Blood vessel assembly from multipotent hemangioma-derived stem cells$444,105
R01 · FY2018 · HL · contact PI
Capillary malformation: From somatic GNAQ mutations and disrupted endothelial biology$442,500
R01 · FY2018 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$452,945
R01 · FY2017 · HL · contact PI
Capillary malformation: From somatic GNAQ mutations and disrupted endothelial biology$442,500
R01 · FY2017 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$452,945
R01 · FY2016 · HL · contact PI
Capillary malformation: From somatic GNAQ mutations and disrupted endothelial biology$442,500
R01 · FY2016 · HL · contact PI
Improving Mitral Compensation in Ischemic Regurgitation$800,185
R01 · FY2015 · HL
Improving Mitral Compensation in Ischemic Regurgitation$814,287
R01 · FY2014 · HL
Building Vascularized Skeletal Muscle for Tissue Engineering/Regeneration$185,673
R21 · FY2014 · AR · contact PI
Improving Mitral Compensation in Ischemic Regurgitation$810,817
R01 · FY2013 · HL
In vivo and in vitro models of hemangioma: tools to identify new therapies$446,398
P01 · FY2013 · AR · contact PI
Building Vascularized Skeletal Muscle for Tissue Engineering/Regeneration$241,238
R21 · FY2013 · AR · contact PI
Core B: Hemangioma Cell and Tissue Core$122,614
P01 · FY2013 · AR · contact PI
Improving Mitral Compensation in Ischemic Regurgitation$905,680
R01 · FY2012 · HL
In vivo and in vitro models of hemangioma: tools to identify new therapies$453,904
P01 · FY2012 · AR · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$430,650
R01 · FY2012 · HL · contact PI
Core B: Hemangioma Cell and Tissue Core$139,546
P01 · FY2012 · AR · contact PI
Tissue Vascularization Using Blood- or Bone-Marrow-derived Progenitor Cells$576,132
R01 · FY2011 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$432,500
R01 · FY2011 · HL · contact PI
In vivo and in vitro models of hemangioma: tools to identify new therapies$389,239
P01 · FY2011 · AR · contact PI
Core B: Hemangioma Cell and Tissue Core$94,702
P01 · FY2011 · AR · contact PI
Tissue Vascularization Using Blood- or Bone-Marrow-derived Progenitor Cells$554,817
R01 · FY2010 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$428,750
R01 · FY2010 · HL · contact PI
In vivo and in vitro models of hemangioma: tools to identify new therapies$387,567
P01 · FY2010 · AR · contact PI
Core B: Hemangioma Cell and Tissue Core$94,740
P01 · FY2010 · AR · contact PI
Tissue Vascularization Using Blood- or Bone-Marrow-derived Progenitor Cells$550,360
R01 · FY2009 · HL · contact PI
Blood vessel assembly from multipotent hemangioma-derived stem cells$425,000
R01 · FY2009 · HL · contact PI
In vivo and in vitro models of hemangioma: tools to identify new therapies$395,080
P01 · FY2009 · AR · contact PI
Core B: Hemangioma Cell and Tissue Core$110,455
P01 · FY2009 · AR · contact PI
Tissue Vascularization Using Blood- or Bone-Marrow-derived Progenitor Cells$551,671
R01 · FY2008 · HL · contact PI
Endothelial Cell Growth and Differentiation in Semilunar Heart Valves$345,613
R01 · FY2008 · HL · contact PI
Annual Meeting of the American Society for Investigative Pathology (with the Nort$18,000
R13 · FY2008 · HL
Cellular Basis of Hemangioma$368,884
P01 · FY2007 · AR · contact PI
Endothelial Cell Growth and Differentiation in Semilunar Heart Valves$345,613
R01 · FY2007 · HL · contact PI
Hemangioma Cell and Tissue Core$77,771
P01 · FY2007 · AR · contact PI
EC Growth and Differentiation in Semilunar Heart Valves$355,935
R01 · FY2006 · HL · contact PI
EC Growth and Differentiation in Semilunar Heart Valves$364,500
R01 · FY2005 · HL
EC Growth and Differentiation in Semilunar Heart Valves$357,455
R01 · FY2004 · HL
VASCULAR CELL DIFFERENTIATION IN TISSUE ENGINEERED STRUC$330,000
R01 · FY2002 · HL
VASCULAR CELL DIFFERENTIATION IN TISSUE ENGINEERED STRUC$330,000
R01 · FY2001 · HL
CORE--SCIENTIFIC$91,598
P01 · FY2001 · CA
REGULATION OF E SELECTIN PROLIFERATING ENDOTHELIUM$91,598
P01 · FY2001 · CA
VASCULAR CELL DIFFERENTIATION IN TISSUE ENGINEERED STRUC$330,000
R01 · FY2000 · HL
CORE--SCIENTIFIC$209,047
P01 · FY2000 · CA
REGULATION OF E SELECTIN PROLIFERATING ENDOTHELIUM$209,047
P01 · FY2000 · CA